Literature DB >> 8033762

The effects of high and low doses of methadone on cigarette smoking.

J M Schmitz1, J Grabowski, H Rhoades.   

Abstract

The effect of methadone dose on the cigarette smoking of five methadone maintenance subjects was studied in a clinical setting. Following a two-week baseline period, daily doses of methadone were either increased (50-80 mg) or decreased (80-50 mg) every two weeks according to an A-B-A-B study design. Continuous self-monitoring was used to collect data on natural smoking behavior, and expired air carbon monoxide (CO) levels were measured at each clinic visit. The predicted methadone dose-related changes in smoking were found in three of the five subjects. Fine-grained analysis of self-monitoring records showed that the proportion of total daily smoking was highest within 4 h after taking methadone for three subjects. CO levels were not significantly associated with smoking rate. The results further support and extend previous reports that methadone may produce dose-related increases in smoking. No reactive effects of self-monitoring were observed, and compliance with this procedure was extremely high, supporting the usefulness of this method for assessing natural smoking behavior in this population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033762     DOI: 10.1016/0376-8716(94)90162-7

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  26 in total

1.  Smoking cessation and chronic pain: patient and pain medicine physician attitudes.

Authors:  W Michael Hooten; Kristin S Vickers; Yu Shi; Kaye L Ebnet; Cynthia O Townsend; Christi A Patten; David O Warner
Journal:  Pain Pract       Date:  2011-04-25       Impact factor: 3.183

2.  Cigarette smoking, illicit drug use, and routes of administration among heroin and cocaine users.

Authors:  P T Harrell; R C Trenz; M Scherer; L R Pacek; W W Latimer
Journal:  Addict Behav       Date:  2012-01-17       Impact factor: 3.913

3.  Evaluating Nicotine Craving, Withdrawal, and Substance Use as Mediators of Smoking Cessation in Cocaine- and Methamphetamine-Dependent Patients.

Authors:  Joshua C Magee; Daniel F Lewis; Theresa Winhusen
Journal:  Nicotine Tob Res       Date:  2015-06-05       Impact factor: 4.244

Review 4.  Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review.

Authors:  Sarah C Akerman; Mary F Brunette; Alan I Green; Daisy J Goodman; Heather B Blunt; Sarah H Heil
Journal:  J Subst Abuse Treat       Date:  2014-12-22

Review 5.  Are Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future Directions.

Authors:  Mollie E Miller; Stacey C Sigmon
Journal:  Nicotine Tob Res       Date:  2015-08       Impact factor: 4.244

6.  Spontaneous reductions in smoking during double-blind buprenorphine detoxification.

Authors:  Mollie E Patrick; Kelly E Dunn; Gary J Badger; Sarah H Heil; Stephen T Higgins; Stacey C Sigmon
Journal:  Addict Behav       Date:  2014-05-05       Impact factor: 3.913

7.  Perceived stress and substance use in methadone-maintained smokers.

Authors:  Ethan Moitra; Bradley J Anderson; Michael D Stein
Journal:  Drug Alcohol Depend       Date:  2013-08-26       Impact factor: 4.492

8.  Contingency management for behavior change: applications to promote brief smoking cessation among opioid-maintained patients.

Authors:  Kelly E Dunn; Kathryn A Saulsgiver; Stacey C Sigmon
Journal:  Exp Clin Psychopharmacol       Date:  2011-02       Impact factor: 3.157

Review 9.  Achieving Smoking Cessation Among Persons with Opioid Use Disorder.

Authors:  Cynthia Vlad; Julia H Arnsten; Shadi Nahvi
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

10.  Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement.

Authors:  Rosemarie A Martin; Damaris J Rohsenow; Jennifer W Tidey
Journal:  J Subst Abuse Treat       Date:  2019-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.